OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Israel
267134
Filed on 2017-12-08
267134
Filed on 2017-12-08
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Australia
2017370731
Filed on 2017-12-08
2017370731
Filed on 2017-12-08
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Canada
3046515
Filed on 2017-12-08
3046515
Filed on 2017-12-08
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Japan
2019-530702
Filed on 2017-12-08
2019-530702
Filed on 2017-12-08
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
India
201917023002
Filed on 2017-12-08
201917023002
Filed on 2017-12-08
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Patent Cooperation Treaty
PCT/US2017/065270
Filed on 2017-12-08
PCT/US2017/065270
Filed on 2017-12-08
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
Switzerland
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
Ireland
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
United Kingdom
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15